[Evaluation of the efficacy and safety of Dolocox in patients with nonspecific back].
E Z YakupovY V TroshinaN K TrutnevaR R GainutdinovaPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The results obtained allow us to recommend short-term use of Dolocox to reduce the risk of potential side effects and increase adherence to therapy.